Health and Social Care Committee

Drugs policy: medicinal cannabis inquiry

Inquiry status: open

Accepting written submissions; the deadline is Friday 8 February 2019.

Scope of the inquiry

As the first part of a wider inquiry into the impact of drugs policy on public health, the Committee is seeking evidence on the usage of medicinal cannabis products. The Committee invites written submissions answering the following:

  • What does the current evidence base tell us about the efficacy of medicinal cannabis?
  • What plans are there for research into the medicinal use of cannabis, and what challenges are faced by that research?
  • How suitable are the current procedures for enabling the use of medicinal cannabis in appropriate cases?
  • Do practitioners have the knowledge and products available to them to confidently prescribe medicinal cannabis?
  • Is the current guidance around prescribing CDMPs fit for purpose? 
  • What can we learn from the legalisation of medicinal cannabis and its practical implementation in other countries?
  • Have recent changes in the scheduling and availability of CDMP, and media attention around this, affected public opinion and behaviours in the UK?

 

 

Send a written submission

Latest evidence

No evidence has been published by the committee yet.

Next meeting(s)

There are currently no public meetings scheduled.

News

Receive RSS updates

Share this page